Brookfield Asset Management Inc. Teva Pharmaceutical Industries LTD Transaction History

Brookfield Asset Management Inc.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Sep 25, 2023	SELL	$7.2 - $9.47 $2.27 Million - $2.98 Million	-314,897 Reduced 72.04%	122,207 $920,000
Q2 2023 Aug 14, 2023	SELL	$7.2 - $9.47 $2.27 Million - $2.98 Million	-314,897 Reduced 72.04%	122,207 $920,000
Q1 2023 Sep 25, 2023	BUY	$8.36 - $11.37 $2.63 Million - $3.58 Million	314,897 Added 257.68%	437,104 $3.87 Million
Q1 2023 May 15, 2023	BUY	$8.36 - $11.37 $3.65 Million - $4.97 Million	437,104 New	437,104 $3.87 Million
Q2 2022 Nov 16, 2022	BUY	$7.38 - $10.4 $4.41 Million - $6.21 Million	597,122 New	597,122 $4.49 Million
Q2 2022 Aug 15, 2022	BUY	$7.38 - $10.4 $90,596 - $127,670	12,276 Added 2.1%	597,122 $4.49 Million
Q1 2022 May 16, 2022	BUY	$7.33 - $9.39 $4.29 Million - $5.49 Million	584,846 New	584,846 $5.49 Million

617

563M

25.2M

5.08M

Ticker TEVA
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 1,110,560,000
Market Cap $19.4B
Description
Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...

Get notified when there are updates to the investment portfolio of Brookfield Asset Management Inc., based on Form 13F filings with the SEC.

Stay updated on Brookfield Asset Management Inc. with notifications on news.